15
Views
4
CrossRef citations to date
0
Altmetric
Miscellaneous

Emerging concepts in cardiovascular disease: should elevated serum uric acid be considered a risk factor?

&
Pages 85-89 | Published online: 23 Feb 2005

Bibliography

  • LOW RK, STOLLER ML: Uric acid-related nephrolithia- sis. UroLN. Am. (1997) 24:(1)135–148.
  • WORTMANN RL: Uric acid and gout. In: The Kidney: Physi-ology and Pathophysiology. Seldin DW, Giebisch G (Eds.), Raven Press, New York (1992):2971–2991.
  • HALL AP, BARRY PE, DAWBER TR et al.: Epidemiology of gout and hyperuricaemia. Am. J. Med. (1967) 42:27–37.
  • MIKKELSEN WM, DODGE HJ, VALKENBURG H: The dis-tribution of serum uric acid values in a population un-selected as to gout or hyperuricaemia: Tecumseh, Michigan, 1959-1960. Am. J. Med. (1965) 39:242–251.
  • GLYNN RJ, CAMPION EW, SILBERT JE: Trends in serum uric acid levels 1961-1980. Arthritis Rheum. (1983) 26:87–93.
  • ROUBENOFF R: Gout and hyperuricaemia. Epriderm, Rheum. Dis, (1990) 16:539–551.
  • GRANTHAM JJ, CHONKO AM: Renal handling of organic anions and cations; excretion of uric acid. In: The Kid-ney. Brenner BM, Rector FC (Eds.), WB Saunders, Philadel-phia (199 0 :483–509.
  • JOSSA F, FARINARO E, PANICO S et al.: Serum uric acid and hypertension: the Olivetti Heart Study. J. Human Hypertens, (1994) 8:677–681.
  • FREEDMAN DS, WILLIAMSON DF, GUNTER EW et al.: Rela-tion of serum uric acid to mortality and ischemic heart disease, the NHANES, epidemiologic follow-up study. Am. J. EpidemioL (1995) 141:637–644.
  • HSYAMUTA K, TOSHIWA H, KOGA Y et al.: Relationship between coronary risk factor and arteriographic feature of coronary atherosclerosis. :lap. Circ. J. (1990) 54:442–447.
  • FESSEL WJ: Hyperuricaemia in health and disease. Semin, Arthritis Rheum. (1972) 1: (1)275–299.
  • REAVEN GM: Syndrome X: 6 years later. J. Intern. Med. (1994) 236(5736) :13–22.
  • KLEIN R, LKEIN BE, CORNON JC et al.: Serum uric acid. Its cardiovascular disease in Evans County, Georgia. Arch. Intern. Med. (1973) 132:401–410.
  • BREAKENRIDSE A: Hypertension and hyperuricaemia. Lancet (1965) 1:15–18.
  • KINSEY D, WALTHER R, SISE HS et al.: Incidence of hy-peruricaemia in 400 hypertensive patients. Circulation (1961) 24:972–973.
  • KAHN HA, MEDALIE JH, NEUFELD HN, RISS E, GOLD-BOURT U: The incidence of hypertension and associ-ated factors. The Israeli Ischemic Heart Disease Study. Am. Heart]. (1972) 84:171–182.
  • SELBY JV, FRIEDMAN GD, QUESENBERRY CP: Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am.]. EpidemioL (1990) 131:1017–1027.
  • THE HYPERTENSION DETECTION AND FOLLOW-UP PROGRAM CO-OPERATIVE RESEARCH GROUP: Mortality findings for stepped-care and referred-care partici-pants in the hypertension detection and follow-up program, stratified by other risk factors. Prey, Med, (1985) 14:312–335.
  • LEVINE W, DYER AR, SHEKELLE RB etal.: Serum uric acid and 11.5 year mortality of middle-aged women: find-ings of the Chicago Heart Association Detection Pro-ject in Industry. J. Clin. EpidemioL (1989) 42:256–267.
  • BENGTSSON C, LAPRDUS L, STENDAHL C etaL: Hyperuri-caemia and risk of cardiovascular disease and overall death: a 12- year follow-up of participants in the popu-lation study of women in Gothenburg, Sweden. Acta Med. Scand, (1988) 224:549–555.
  • LEAVERTON PE, SORLIE PD, KLEINMAN JC et al.: Repre-sentativeness of the Framingham risk model for coro-nary heart disease mortality: a comparison with a national cohort study.]. Chronic Dis, (1987) 40:135–148.
  • MARINOFF SC, LEMPERT P, MANDEL EE: Association of hypercholesterolemia with hyperuricaemia. A review of the literature. Chicago Med. Quart. (1962) 22:135–148.
  • FACCHINI F, CHEN Y-DI, HOLLENBECK CB, REAVEN GM: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. AMA (1991) 266:3008–3011.
  • ZAVARONI I, MAZZA S, FANTUZZI MChanges in in-sulin and lipid metabolism in males with asympto-matic hyperuricaemia.]. Intern. Med. (1993) 234:24–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.